https://www.selleckchem.com/Proteasome.html
73, t (36)=2.15, p=.04, OR=2.08. This effect was not moderated by treatment condition (β=-1.38, t (13)=-1.33, p=.2 and did not change when controlling for known risk factors for depression, including sex, age, body-mass index, socio-economic status, T1 anxiety disorder, nor T1 sleep disturbance, anxiety, or depressive symptoms (β=0.91, t (31)=2.14, p=.04). Results highlight potential immuno-endocrine dysregulation as an underlying risk factor for adolescent first-onset depression, and may inform the development of targeted, preventative bio
Like
Comment
Share
